These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 10704146

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Association of interferon gamma, tumor necrosis factor alpha and interleukin 6 serum levels with systemic lupus erythematosus activity.
    Robak E, Sysa-Jedrzejewska A, Dziankowska B, Torzecka D, Chojnowski K, Robak T.
    Arch Immunol Ther Exp (Warsz); 1998; 46(6):375-80. PubMed ID: 9883317
    [Abstract] [Full Text] [Related]

  • 3. Relationship of oncogenes (sFas, Bcl-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythematosus.
    Miret C, Font J, Molina R, Garcia-Carrasco M, Filella X, Ramos M, Cervera R, Ballesta A, Ingelmo M.
    Anticancer Res; 2001; 21(4B):3053-9. PubMed ID: 11712810
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Subclinical disease activity in systemic lupus erythematosus: immunoinflammatory markers do not normalize in clinical remission.
    Wais T, Fierz W, Stoll T, Villiger PM.
    J Rheumatol; 2003 Oct; 30(10):2133-9. PubMed ID: 14528506
    [Abstract] [Full Text] [Related]

  • 7. Circulating interleukin-6 type cytokines in patients with systemic lupus erythematosus.
    Robak E, Sysa-Jedrzejowska A, Stepień H, Robak T.
    Eur Cytokine Netw; 1997 Sep; 8(3):281-6. PubMed ID: 9346362
    [Abstract] [Full Text] [Related]

  • 8. Cytokine concentration in serum of lupus erythematosus patients: the effect on acute phase response.
    Lacki JK, Leszczynski P, Kelemen J, Müller W, Mackiewicz SH.
    J Med; 1997 Sep; 28(1-2):99-107. PubMed ID: 9249616
    [Abstract] [Full Text] [Related]

  • 9. [The importance of determination of interleukin-10 in the blood of patients with systemic lupus erythematosus].
    Scudla V, Horák P, Faltýnek L, Pospísil Z, Budíková M, Hermanová Z.
    Cas Lek Cesk; 1998 Jan 26; 137(2):44-7. PubMed ID: 9511265
    [Abstract] [Full Text] [Related]

  • 10. Markers of inflammation and atherosclerosis in Egyptian patients with systemic lupus erythematosus.
    Sabry AA, Elbasyouni SR, Kalil AM, Abdel-Rahim M, Mohsen T, Sleem A.
    Nephrology (Carlton); 2006 Aug 26; 11(4):329-35. PubMed ID: 16889573
    [Abstract] [Full Text] [Related]

  • 11. [Proinflammatory cytokines in inactive lupus erythematosus patients].
    Lesiak A, Sysa-Jedrzejowska A, Narbutt J, Lukamowicz J, Robak E, Wozniacka A.
    Przegl Lek; 2005 Aug 26; 62(9):838-42. PubMed ID: 16541713
    [Abstract] [Full Text] [Related]

  • 12. Pregnancy, cytokines, and disease activity in systemic lupus erythematosus.
    Doria A, Ghirardello A, Iaccarino L, Zampieri S, Punzi L, Tarricone E, Ruffatti A, Sulli A, Sarzi-Puttini PC, Gambari PF, Cutolo M.
    Arthritis Rheum; 2004 Dec 15; 51(6):989-95. PubMed ID: 15593367
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Influence of functional interleukin 10/tumor necrosis factor-alpha polymorphisms on interferon-alpha, IL-10, and regulatory T cell population in patients with systemic lupus erythematosus receiving antimalarial treatment.
    López P, Gómez J, Prado C, Gutiérrez C, Suárez A.
    J Rheumatol; 2008 Aug 15; 35(8):1559-66. PubMed ID: 18597405
    [Abstract] [Full Text] [Related]

  • 16. Clinical significance of nailfold capillaroscopy in systemic lupus erythematosus: correlation with endothelial cell activation markers and disease activity.
    Kuryliszyn-Moskal A, Ciolkiewicz M, Klimiuk PA, Sierakowski S.
    Scand J Rheumatol; 2009 Aug 15; 38(1):38-45. PubMed ID: 18991188
    [Abstract] [Full Text] [Related]

  • 17. Analysis of interleukin-6, interleukin-10 and leukemia inhibitory factor (LIF) production by peripheral blood cells from patients with systemic lupus erythematosus identifies LIF as a potential marker of disease activity.
    Viallard JF, Taupin JL, Miossec V, Pellegrin JL, Moreau BL.
    Eur Cytokine Netw; 1999 Mar 15; 10(1):17-24. PubMed ID: 10210768
    [Abstract] [Full Text] [Related]

  • 18. [Clinical and pathogenic significance of tumor necrosis factor-alpha in systemic lupus erythematosus].
    Borodin AG, Baranov AA, Kliukvina NG, Abaĭtova NE, Nasonov EL.
    Ter Arkh; 2002 Mar 15; 74(5):32-5. PubMed ID: 12087902
    [Abstract] [Full Text] [Related]

  • 19. Proinflammatory interferon-gamma--inducing monokines (interleukin-12, interleukin-18, interleukin-15)--serum profile in patients with systemic lupus erythematosus.
    Robak E, Robak T, Wozniacka A, Zak-Prelich M, Sysa-Jedrzejowska A, Stepien H.
    Eur Cytokine Netw; 2002 Mar 15; 13(3):364-8. PubMed ID: 12231481
    [Abstract] [Full Text] [Related]

  • 20. The association of cytokines with disease activity and damage scores in systemic lupus erythematosus patients.
    McCarthy EM, Smith S, Lee RZ, Cunnane G, Doran MF, Donnelly S, Howard D, O'Connell P, Kearns G, Ní Gabhann J, Jefferies CA.
    Rheumatology (Oxford); 2014 Sep 15; 53(9):1586-94. PubMed ID: 24706988
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.